BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11363839)

  • 1. Delavirdine/protease inhibitor interactions.
    Gilden D
    GMHC Treat Issues; 1996 Sep; 10(9):11-2. PubMed ID: 11363839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nevirapine and delavirdine plus protease inhibitors.
    GMHC Treat Issues; 1996 Apr; 10(4):8. PubMed ID: 11363709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delavirdine dilemma at the FDA. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1996 Dec; 10(12):4-5. PubMed ID: 11364017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delavirdine gets the green light.
    Vazquez E
    Posit Aware; 1997; 8(3):18-9. PubMed ID: 11364419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M
    AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delavirdine gains approval as second NNRTI for anti-HIV combination regimens.
    Crit Path AIDS Proj; 1997; (No 32):29-30. PubMed ID: 11364439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delavirdine data: skewed or skewered?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Feb; 3(2):42-6. PubMed ID: 11364099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. '96-'97 new drugs and the nominees for 1997 are...
    Notes Undergr; 1997; (No 35):suppl 1-2. PubMed ID: 11364566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New combination medications].
    Agosto M
    Sidahora; 1997; ():43-6. PubMed ID: 11364501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delavirdine (Rescriptor) approved.
    James JS
    AIDS Treat News; 1997 Apr; (No 269):1-3. PubMed ID: 11364252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-nucleoside reverse transcriptase inhibitors.
    Bowers M
    BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Now there are eleven, but so what?
    Gilden D
    GMHC Treat Issues; 1997; 11(4/5):1-3. PubMed ID: 11364371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanded access for delavirdine.
    Posit Aware; 1996; 7(3):5-6. PubMed ID: 11363426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new class of anti-HIV drugs.
    Treat Rev; 1996 Aug; (No 22):8-9. PubMed ID: 11363816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral update.
    PI Perspect; 1996 Nov; (No 20):8-9. PubMed ID: 11363972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of antiretroviral drugs.
    Hoetelmans RM
    Antivir Ther; 1999; 4 Suppl 3():29-41. PubMed ID: 16021869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delavirdine expanded access program.
    BETA; 1996 Jun; ():7. PubMed ID: 11363651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz's complications.
    GMHC Treat Issues; 1998 May; 12(5):6. PubMed ID: 11365477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delavirdine levels in women.
    Vazquez E
    Posit Aware; 1997; 8(4):14. PubMed ID: 11364481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.